Reckitt Benckiser Group plc Class Action Update
Levi & Korsinsky, LLP informs investors about a significant class action securities lawsuit involving Reckitt Benckiser Group plc (OTC PINK: RBGLY). This lawsuit aims to represent those affected by alleged securities fraud.
Understanding the Class Action
The class action seeks to recover losses incurred by investors during a noted period of securities fraud. The allegations primarily concern misleading statements made by the company's executives regarding the risks associated with their products.
Key Allegations
The essence of the lawsuit revolves around claims that Reckitt's cow's milk-based formula, Enfamil, was associated with an increased risk of preterm infants developing a serious gastrointestinal condition known as NEC. Furthermore, it is alleged that Reckitt concealed the impact of this knowledge on their sales and exposure to legal ramifications.
What Investors Should Know
If you are an investor in Reckitt Benckiser Group plc and believe you may have lost money due to these fraudulent activities, there are important timelines to consider. Specifically, you have until August 4, 2025, to submit your request to the court to appoint you as a lead plaintiff.
Your Rights as a Class Member
Participating in the class action does not require you to act as a lead plaintiff. This means any investor can potentially share in the outcome of the lawsuit without the obligation of being the primary representative in court.
No Costs Involved
For investors worried about costs, it is essential to understand that involvement in this lawsuit as a class member may lead to compensation without incurring any personal financial burden. There are no fees unless there is a recovery of costs due to the successful outcome of the class action.
The Strength of Levi & Korsinsky
Levi & Korsinsky has a solid reputation in securing substantial settlements for investors. With over two decades of experience, this law firm has made significant strides in protecting shareholders and has been consistently recognized among the top firms in securities litigation. Their team provides robust support and expertise to effectively represent investors in complex cases like this one.
Contact Information for Investors
Investors needing more information or support can reach out to Levi & Korsinsky, LLP. You can contact Joseph E. Levi, Esq. directly via telephone at (212) 363-7500.
Visit Our Website
For more details about Levi & Korsinsky's services and the ongoing cases, please visit their website. They are dedicated to keeping all stakeholders informed and engaged.
Frequently Asked Questions
What is the deadline to join the class action?
The deadline to request appointment as a lead plaintiff is August 4, 2025.
What should I do if I experienced losses as an investor?
If you experienced losses, you should gather your investment records and consider reaching out to Levi & Korsinsky for guidance.
Do I need to pay to join the class action?
No, there are no upfront costs to participate in the class action lawsuit.
What are the main allegations against Reckitt Benckiser Group plc?
The primary allegations involve false statements regarding the safety of their product, Enfamil, which put vulnerable infants at risk.
How has Levi & Korsinsky helped other investors?
Levi & Korsinsky has a track record of winning large settlements for shareholders, making them a strong choice for representation in securities litigation.
